Result of AGM

RNS Number : 2859Q

Life Science REIT PLC

27 June 2022

 

27 June 2022

LEI: 213800RG7JNX7K8F7525

Life Science REIT plc

("Life Science REIT" or the "Company")

Result of AGM

Life Science REIT (AIM: LABS), the real estate investment trust focused on UK life science properties, announces that at its Annual General Meeting ("AGM") held on 24 June 2022 all the resolutions set out in the Notice of Annual General Meeting were passed.

All resolutions were voted on by way of a poll.  The results of the poll for each resolution were as follows:

Resolution	For		Against		Votes Withheld (No. of shares)
	No. of shares	%	No. of shares	%
1.  To receive and approve the annual report and financial statements	170,793,774	100	0	0	15,000
2.  To receive and approve the Directors' remuneration report	170,713,974	99.99	16,614	0.01	78,186
3.  To receive and approve the Directors' remuneration policy	170,710,974	99.99	16,614	0.01	81,186
4.  To elect Claire Boyle as a Director of the Company	164,329,658	96.21	6,479,116	3.79	0
5.  To elect Sally Ann Forsyth as a Director of the Company	170,808,774	100	0	0	0
6.  To elect Michael Taylor as a Director of the Company	170,803,774	100	0	0	5,000
7.  To elect Richard Howell as a Director of the Company	170,793,774	99.99	10,000	0.01	5,000
8.  To appoint Deloitte LLP as Auditor to the Company	170,797,274	99.99	10,500	0.01	1,000
9.  To authorise the Audit and Risk Committee to determine the remuneration of the Auditor to the Company	170,791,774	99.99	16,000	0.01	1,000
10.  That the Directors be authorised to allot shares in the Company	167,827,629	98.25	2,981,145	1.75	0
11.  To authorise the Directors to disapply pre-emption rights*	164,771,774	99.98	30,000	0.02	6,007,000
12.  To authorise the Directors to disapply pre-emption rights for the purposes of financing an acquisition or other capital investment*	164,767,774	99.98	35,000	0.02	6,006,000
13.  That the Company be authorised to make market purchases of ordinary shares of £0.01 each in the capital of the Company*	170,798,774	99.99	10,000	0.01	0
14.  That a general meeting, other than an AGM, may be called on not less than 14 clear days' notice*	170,805,774	99.99	3,000	0.01	0

*special resolution

NOTES:
1.	All resolutions were passed.
2.	Proxy appointments which gave discretion to the Chair of the AGM have been included in the "For" total for the appropriate resolution.
3.	Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.
4.	A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.
5.	The number of shares in issue at 6:00 p.m. on 22 J une 2022 was 350,000,000 ordinary shares, carrying one vote each, and at that time, the Company did not hold any shares in treasury.
6.	The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at https://lifesciencereit.co.uk/investors/shareholder-information/

Enquiries:

Link Company Matters Limited - Company Secretary
[e-mail]
Ironstone Asset Management - Investment Adviser
Simon Farnsworth	via Buchanan below
Panmure Gordon (UK) Limited - Nominated Adviser and Joint Corporate Broker	[phone]
Atholl Tweedie / Sapna Shah / Philip Shields / Chloe Ponsonby
Jefferies International Limited - Joint Corporate Broker	[phone]
Tom Yeadon / Andrew Morris / Oliver Nott
Buchanan - Financial PR	[phone]
Mark Court / Henry Wilson / Verity Parker
[e-mail]

Notes to editors

Life Science REIT plc is a property business focused solely on the UK's growing life science sector, specifically targeting opportunities in the "Golden Triangle" research and development hubs of Oxford, Cambridge and London St Pancras. The Company's intention is to become the property provider of choice for life science companies in the UK, whilst enabling shareholders to gain exposure to a specific growth sector.

The objective of the Company's investment policy is focused on capital growth, whilst also providing a growing level of income, by investing primarily in a diversified portfolio of properties that are leased, or intended to be leased, to occupiers operating in the life science sector in the UK.

Life Science REIT joined the AIM market of the London Stock Exchange on 19 November 2021, having raised £350 million in its IPO. Its shares trade under the ticker LABS.

Further information is available at https://lifesciencereit.co.uk

 

END

 

 

RAGFRMPTMTTTMAT